Amenorrhea induced by chemotherapy in Premenopausal Breast Cancer Patients (Retrospective Study)

Assessment of outcome of Ovarian Cancer Treatment; Retrospective cohort study

Anti-müllerian hormone, inhibin B and antral follicle count as markers of premature ovarian failure in women with type I diabetes mellitus

Correlation Between Serum Anti-Müllerian Hormone Levels and Antral Follicle Count in Prediction of Clinical Pregnancy in Women with Unexplained Infertility Undergoing ICSI Cycles

Changes in sex hormones profile among pre & peri-menopausal breast cancer patients receiving systemic chemotherapy

Variation of serum complements and gonadotropins hormones in breast cancer

Using Anti-Müllerian Hormone and Serum Estradiol to Predict Ovarian Hyperstimulation Syndrome in Patients Using Antagonist Protocol During IVF/ICSI Cycles

Anti-Mullerian hormone (AMH) and antral follicular count after prolonged use of hormonal contraception

The Predictive Value of Anti-Mullerian Hormone on Pregnancy Rate After IVF

SERUM ANTI- MULLERIAN HORMONE IS A BETTER PREDICTOR OF OVARIAN RESERVE AT THE EARLY FOLLICULAR PHASE.